Income Statement
COEPTIS THERAPEUTICS HOLDINGS, INC.
ZSQR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Revenue
|
1.36 | 0.00 | 0.00 | 0.00 | - | - |
|
Cost of Revenue
|
0.18 | 0.00 | 0.00 | 0.00 | - | - |
|
Gross Profit
|
1.18 | 0.00 | 0.00 | 0.00 | - | - |
|
Operating Expenses
|
14.23 | 10.05 | 21.49 | 34.20 | 0.68 | 0.07 |
|
Research & Development
|
1.28 | 2.33 | 6.67 | 0.02 | - | - |
|
Selling, General & Administrative
|
0.11 | 0.95 | 3.95 | 34.17 | - | - |
|
Other Operating Expenses
|
- | - | - | - | - | - |
|
Operating Income
|
-13.04 | -10.05 | -21.49 | -34.20 | -0.68 | -0.07 |
|
Non-Operating Income
|
0.77 | -0.82 | 0.22 | -3.38 | - | - |
|
Interest Income
|
- | - | - | - | 0.01 | 0.00 |
|
Interest Expense
|
- | - | 0.11 | 0.22 | - | - |
|
Other Non-Op Income / Expense
|
0.01 | 0.15 | -0.22 | - | - | - |
|
Income Before Tax
|
-12.28 | -10.88 | -21.27 | -37.57 | - | - |
|
Income Tax Expense
|
-0.36 | 0.00 | 0.00 | 0.00 | - | - |
|
Non-Controlling Interest
|
-0.36 | 1.06 | - | - | - | - |
|
Net Income
|
-11.92 | -10.88 | -21.27 | -37.57 | 15.23 | -0.07 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY |
|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - |
|
EBITDA
|
-11.86 | -9.05 | -20.49 | -33.19 | -0.68 | -0.07 |
|
Earnings Per Share (Basic)
|
-2.81 | -5.65 | - | - | 1.62 | - |
|
Diluted EPS
|
-2.81 | -5.65 | - | - | - | - |
|
Weighted Average Shares
|
4.23 | 1.92 | - | - | 7.50 | - |
|
Diluted Weighted Avg Shares
|
4.23 | 1.92 | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - |